Kashmira Shah
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Hormonal Regulation and Hypertension, Ion channel regulation and function, Cardiac electrophysiology and arrhythmias, Adrenal Hormones and Disorders, Aldose Reductase and Taurine
Most-Cited Works
- → 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice(2005)362 cited
- → Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo(1997)218 cited
- → Cloning of a Cysteine Protease Required for the Molting of Onchocerca volvulus Third Stage Larvae(1996)96 cited
- → Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels(1999)81 cited
- → Identification and validation of genes affecting aortic lesions in mice(2010)57 cited
- → Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome(2005)54 cited
- → Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis(2020)53 cited
- → Bis-aryl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1(2008)47 cited
- → Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I(2008)47 cited
- → A Small Molecule Very Late Antigen–4 Antagonist Can Inhibit Ovalbumin-induced Lung Inflammation(2003)44 cited